Bristol-Myers Squibb buy Guggenheim
Start price
23.12.25
/
50%
€46.50
Target price
23.12.26
-
Performance (%)
10.00%
Price
17.04.26
€51.15
Summary
This prediction is currently active. With a performance of 10.00%, the BUY prediction by Guggenheim for Bristol-Myers Squibb is trending in the right direction. This prediction currently runs until 23.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.341% | 2.341% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Guggenheim for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.69
08.04.26
08.04.26
€61.69
08.04.27
08.04.27
2.94%
17.04.26
17.04.26
